Life Science Market Research Reports

Global Prosthetics and Orthotics Market By Product Type (Prosthetics, Orthotics), By Age Group (Pediatric, Adult, Geriatric), By Application (Trauma & Accident Rehabilitation, Diabetes-Related Limb Loss, Vascular Diseases, Congenital Limb Deficiencies, Osteoarthritis, Cerebral Palsy, Stroke Rehabilitation, Sports Injuries, Spinal Disorders, Neuromuscular Disorders, Others), By End User (Hospitals, Prosthetic & Orthotic Clinics, Rehabilitation Centers, Ambulatory Surgical Centers (ASCs), Long-Term Care Facilities, Military & Veterans Healthcare Facilities, Others), By Region and Companies — Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025–2035

Market Overview The Global Prosthetics and Orthotics Market size is expected to be worth around US$ 11.4 Billion by 2035 from US$ 7.1 Billion in 2025, growing at a CAGR of 4.8% durin...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2026
- Pages: 269
- US $3,999 Onwards
- Formats:
Global Exosomes Skincare Market By Product Type (Exosome-Based Serums, Exosome-Based Creams & Moisturizers, Exosome-Based Masks, Exosome-Based Ampoules & Concentrates, Exosome-Based Eye Care Products, Exosome-Based Cleansers & Toners, Exosome-Based Sunscreens, Others), By Exosome Source (Human Stem Cell-Derived Exosomes, Mesenchymal Stem Cell (MSC)-Derived Exosomes, Plant-Derived Exosomes, Animal-Derived Exosomes), By Application (Facial Skincare, Post-Aesthetic Procedure Recovery, Anti-Aging Treatment, Skin Barrier Repair, Hyperpigmentation Management, Acne Management, Scar Management, Hair Restoration & Scalp Care, Others), By Consumer Group (Women, Men, Unisex), By Distribution Channel (Offline, Online), By Region and Companies — Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025–2035

Market Overview The Global Exosomes Skincare Market size is expected to be worth around US$ 4.4 Billion by 2035 from US$ 1.0 Billion in 2025, growing at a CAGR of 15.9% during the fo...
- ★★★★★
  
  ★★★★★
  
  (142)
- Oct 2026
- Pages: 369
- US $3,999 Onwards
- Formats:
Global Stem Cell Therapy Market Size, Share and Report Analysis By Therapy Type (Autologous, Allogeneic), By Cell Source (Adult stem cells , Adipose tissue‑derived stem cells, Bone marrow‑derived stem cells, Placenta / umbilical cord‑derived cells, Induced pluripotent stem cells (iPSC), Embryonic stem cells (ESC)), By Application (Hematologic disorders, Musculoskeletal disorders, Cardiovascular diseases, Neurological disorders, Wounds, burns & surgical applications, Autoimmune , Other indications (ocular, hepatic, etc.)), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Market Overview Global Stem Cell Therapy Market size is expected to be worth around US$ 4805.8 Million by 2035 from US$ 545.1 Million in 2025, growing at a CAGR of 24.3% during the f...
- ★★★★★
  
  ★★★★★
  
  (45)
- Oct 2026
- Pages: 329
- US $3,999 Onwards
- Formats:
Global Radiopharmaceuticals Market Size, Share and Report Analysis By Type (Therapeutic radiopharmaceuticals, Diagnostic radiopharmaceuticals), By Application (Oncology, Cardiology, Neurology, Gastroenterology, Nephrology, Other), By Radioisotopes (Technetium‑99m (Tc‑99m), Fluorine‑18 (F‑18), Iodine‑131 (I‑131), Lutetium‑177 (Lu‑177), Gallium‑68 (Ga‑68), Yttrium‑90 (Y‑90), Other isotopes), By End-user (Hospitals, Diagnostic / imaging centers, Specialty / cancer centers, Academic & research institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Market Overview Global Radiopharmaceuticals Market size is expected to be worth around US$ 18.3 Billion by 2035 from US$ 7.0 Billion in 2025, growing at a CAGR of 10.2% during the fo...
- ★★★★★
  
  ★★★★★
  
  (102)
- Oct 2026
- Pages: 232
- US $3,999 Onwards
- Formats:
Global Monoclonal Antibodies Market Size, Share and Report Analysis By Indication (Oncology / cancer, Autoimmune diseases, Inflammatory / immune‑mediated, Infectious diseases, Neurological & other indications), By Production (In vitro, In vivo), By End-user (Hospitals / hospital pharmacies, Specialty centers / clinics, Retail pharmacies, Online / other channels), By Source (Human, Humanized, Chimeric, Murine), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Market Overview Global Monoclonal Antibodies Market size is expected to be worth around US$ 849.3 Billion by 2035 from US$ 285.7 Billion in 2025, growing at a CAGR of 11.5% during th...
- ★★★★★
  
  ★★★★★
  
  (42)
- Oct 2026
- Pages: 286
- US $3,999 Onwards
- Formats:
Global Immune Checkpoint Inhibitors Market Size, Share and Report Analysis By Drug Class (PD‑1 inhibitors, PD‑L1 inhibitors, CTLA‑4 inhibitors, Other) , By Cancer type (Lung Cancer (NSCLC/SCLC), Melanoma, Renal cell carcinoma, Bladder cancer, Head & neck cancers, Hodgkin lymphoma & other heme malignancies, Other solid tumors), By Route of Administration (Intravenous, Subcutaneous, Other routes), By End-user (Hospitals & hospital pharmacies, Specialty oncology clinics, Academic & research centers, Retail/other pharmacies & settings), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Market Overview Global Immune Checkpoint Inhibitors Market size is expected to be worth around US$ 225.0 Billion by 2035 from US$ 53.5 Billion in 2025, growing at a CAGR of 15.4% dur...
- ★★★★★
  
  ★★★★★
  
  (91)
- Sep 2026
- Pages: 293
- US $3,999 Onwards
- Formats:

« Previous 1 2 3 4 5 … 383 Next »